Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Distinct immune characteristics distinguish hereditary and idiopathic chronic pancreatitis
Bomi Lee, Julia Z. Adamska, Hong Namkoong, Melena D. Bellin, Josh Wilhelm, Gregory L. Szot, David M. Louis, Mark M. Davis, Stephen J. Pandol, Aida Habtezion
Bomi Lee, Julia Z. Adamska, Hong Namkoong, Melena D. Bellin, Josh Wilhelm, Gregory L. Szot, David M. Louis, Mark M. Davis, Stephen J. Pandol, Aida Habtezion
View: Text | PDF
Concise Communication Gastroenterology Immunology

Distinct immune characteristics distinguish hereditary and idiopathic chronic pancreatitis

  • Text
  • PDF
Abstract

Chronic pancreatitis (CP) is considered an irreversible fibroinflammatory pancreatic disease. Despite numerous animal model studies, questions remain about local immune characteristics in human CP. We profiled pancreatic immune cell characteristics in control organ donors and CP patients including those with hereditary and idiopathic CP undergoing total pancreatectomy with islet autotransplantation. Flow cytometric analysis revealed a significant increase in the frequency of CD68+ macrophages in idiopathic CP. In contrast, hereditary CP samples showed a significant increase in CD3+ T cell frequency, which prompted us to investigate the T cell receptor β (TCRβ) repertoire in the CP and control groups. TCRβ sequencing revealed a significant increase in TCRβ repertoire diversity and reduced clonality in both CP groups versus controls. Interestingly, we observed differences in Vβ-Jβ gene family usage between hereditary and idiopathic CP and a positive correlation of TCRβ rearrangements with disease severity scores. Immunophenotyping analyses in hereditary and idiopathic CP pancreases indicate differences in innate and adaptive immune responses, which highlights differences in immunopathogenic mechanisms of disease among subtypes of CP. TCR repertoire analysis further suggests a role for specific T cell responses in hereditary versus idiopathic CP pathogenesis, providing insights into immune responses associated with human CP.

Authors

Bomi Lee, Julia Z. Adamska, Hong Namkoong, Melena D. Bellin, Josh Wilhelm, Gregory L. Szot, David M. Louis, Mark M. Davis, Stephen J. Pandol, Aida Habtezion

×

Figure 1

CD68+ macrophages are predominant in idiopathic CP compared with hereditary CP.

Options: View larger image (or click on image) Download as PowerPoint
CD68+ macrophages are predominant in idiopathic CP compared with heredit...
(A) Immunohistochemistry staining using the pan-leukocyte marker CD45 (original magnification, ×400). Scale bars: 100 μm. The percentage of CD45+ cells among total pancreatic cells is presented as a dot plot. Mean ± SD; unpaired 2-tailed t test. (B) The frequency of CD3+ T cells and CD68+ cells in live CD45+ cells from control (n = 8) and CP (n = 24) samples. Mean ± SD; unpaired 2-tailed t test was used. (C) Graphs show frequencies of CD68+ cells and their subsets in live CD45+ cells from control (n = 8), hereditary CP (n = 15), and idiopathic CP (n = 9) tissues. Mean ± SD; 1-way ANOVA with Tukey’s multiple-comparisons test. (D) Heatmap represents expression levels of analytes with MFI values by the human 62 multiplex Luminex assay (t test, P < 0.05, FDR < 0.25). Fold change in the average expression of each analyte in idiopathic versus hereditary CP. (E) Comparison of MFI values of the most differentially regulated chemokine (CCL7) between hereditary (n = 17) and idiopathic (n = 8) CP. Mean ± SD; unpaired 2-tailed t test was used. *P < 0.05, **P < 0.01, ***P < 0.001. HPF, high-power field.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts